Puma Biotechnology
PBYI
PBYI
128 hedge funds and large institutions have $1.07B invested in Puma Biotechnology in 2016 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 61 increasing their positions, 24 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
45% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 42
46% less capital invested
Capital invested by funds: $2B → $1.07B (-$932M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
128
Holding in Top 10
1
Calls
$23.6M
Puts
$12.3M
Top Buyers
| 1 | +$51.1M | |
| 2 | +$35.1M | |
| 3 | +$31.7M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$20.1M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$19.3M |
Top Sellers
| 1 | -$69M | |
| 2 | -$43.4M | |
| 3 | -$15.6M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$10.1M |
| 5 |
Asset Management One
Tokyo,
Japan
|
-$8.96M |